GA Depot, a long-acting glatiramer acetate, vs placebo in patients with relapsing multiple sclerosis: A randomized phase 3 clinical trial
Ehud Marom, Uri Danon, A. Karni, Nadav Bleich Kimelman et al.
Journal
Multiple Sclerosis Journal
Topics
Multiple Sclerosis Research Studies
article
GA Depot, a long-acting glatiramer acetate, vs placebo in patients with relapsing multiple sclerosis: A randomized phase 3 clinical trial
Ehud Marom, Uri Danon, A. Karni, Nadav Bleich Kimelman, Laura Popper, Amit Bar‐Or, Albert Miller, Hadar Kolb, A. N. Boyko, Shai Rubnov, Jeffrey A Cohen, Joseph R Berger, Robert Zivadinov
article en
Abstract
No abstract available for this paper.
Publication Tag
Multiple Sclerosis JournalVol. 32(2)
Institutions
Cleveland Clinic (US), Tel Aviv Sourasky Medical Center (IL), Pirogov Russian National Research Medical University (RU), Buffalo Psychiatric Center (US), Mapi Pharma (Israel) (IL), University at Buffalo, State University of New York (US), University of Pennsylvania (US), Icahn School of Medicine at Mount Sinai (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
GA Depot, a long-acting glatiramer acetate, vs placebo in patients with relapsing multiple sclerosis: A randomized phase 3 clinical trial — Ehud Marom, Uri Danon, et al. · Multiple Sclerosis Journal (2026) | TGRS Research Map | TGRS